These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 17916319

  • 1. Central retinal vein occlusion case-control study.
    Koizumi H, Ferrara DC, Bruè C, Spaide RF.
    Am J Ophthalmol; 2007 Dec; 144(6):858-863. PubMed ID: 17916319
    [Abstract] [Full Text] [Related]

  • 2. Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population.
    Narayanasamy A, Subramaniam B, Karunakaran C, Ranganathan P, Sivaramakrishnan R, Sharma T, Badrinath VS, Roy J.
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1441-6. PubMed ID: 17389469
    [Abstract] [Full Text] [Related]

  • 3. Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
    Pinna A, Carru C, Solinas G, Zinellu A, Carta F.
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2747-52. PubMed ID: 17525208
    [Abstract] [Full Text] [Related]

  • 4. Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma.
    Wittström E, Ponjavic V, Lövestam-Adrian M, Larsson J, Andréasson S.
    Acta Ophthalmol; 2010 Feb; 88(1):86-90. PubMed ID: 19432876
    [Abstract] [Full Text] [Related]

  • 5. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
    Glueck CJ, Ping Wang, Hutchins R, Petersen MR, Golnik K.
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MTHFR C677T mutation in central retinal vein occlusion: a case-control study in Chinese population.
    Gao W, Wang YS, Zhang P, Wang HY.
    Thromb Res; 2008 Jul; 121(5):699-703. PubMed ID: 17719079
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalent misconceptions about acute retinal vascular occlusive disorders.
    Hayreh SS.
    Prog Retin Eye Res; 2005 Jul; 24(4):493-519. PubMed ID: 15845346
    [Abstract] [Full Text] [Related]

  • 11. Systemic considerations in bilateral central retinal vein occlusion.
    Tomasini DN, Segu B.
    Optometry; 2007 Aug; 78(8):402-8. PubMed ID: 17662929
    [Abstract] [Full Text] [Related]

  • 12. Plasma thiols and taurine levels in central retinal vein occlusion.
    Pinna A, Zinellu A, Franconi F, Carru C.
    Curr Eye Res; 2010 Jul; 35(7):644-50. PubMed ID: 20597650
    [Abstract] [Full Text] [Related]

  • 13. Activated protein C resistance is a risk factor for central retinal vein occlusion.
    Marcucci R, Bertini L, Liotta AA, Rogolino A, Antonucci E, Ilari I, Pepe G, Prisco D.
    Ann Ital Med Int; 2000 Jul; 15(3):195-8. PubMed ID: 11059059
    [Abstract] [Full Text] [Related]

  • 14. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
    Noma H, Funatsu H, Mimura T, Harino S, Hori S.
    Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
    [Abstract] [Full Text] [Related]

  • 15. Risk factors associated with branch vs. central retinal vein occlusion.
    Appiah AP, Trempe CL.
    Ann Ophthalmol; 1989 Apr; 21(4):153-5, 157. PubMed ID: 2729819
    [Abstract] [Full Text] [Related]

  • 16. Central retinal vein occlusion associated with cilioretinal artery occlusion.
    Hayreh SS, Fraterrigo L, Jonas J.
    Retina; 2008 Apr; 28(4):581-94. PubMed ID: 18398361
    [Abstract] [Full Text] [Related]

  • 17. Retinal vein occlusions in patients taking warfarin.
    Browning DJ, Fraser CM.
    Ophthalmology; 2004 Jun; 111(6):1196-200. PubMed ID: 15177971
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma homocysteine and cysteine levels in retinal vein occlusion.
    Pinna A, Carru C, Zinellu A, Dore S, Deiana L, Carta F.
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4067-71. PubMed ID: 16936125
    [Abstract] [Full Text] [Related]

  • 20. Serum PON1 arylesterase activity in relation to hyperhomocysteinaemia and oxidative stress in young adult central retinal venous occlusion patients.
    Angayarkanni N, Barathi S, Seethalakshmi T, Punitham R, Sivaramakrishna R, Suganeswari G, Tarun S.
    Eye (Lond); 2008 Jul; 22(7):969-74. PubMed ID: 18084236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.